Clinical Trials Logo

Clinical Trial Summary

The purpose of this study was to compare the difference in the stent patency duration between side-by-side fully covered self-expanding metal stents (SEMS) and side-by-side plastic stents in patients with malignant hilar biliary obstruction.


Clinical Trial Description

In the case of distal common bile duct obstruction, the SEMS was reported to be clinically superior to the plastic stent in previous studies. However, there are few studies comparing the two methods in patients with malignant hilar biliary obstruction. In contrast to the distal common bile duct obstruction, the advantage of plastic stents over SEMSs exists, and plastic stents are used commonly in real clinical practice. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03857958
Study type Interventional
Source Seoul National University Hospital
Contact Min su You, MD
Phone 82-2-2072-2228
Email bass105@hanmail.net
Status Recruiting
Phase N/A
Start date February 15, 2019
Completion date June 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT02916199 - Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method N/A
Completed NCT05068739 - Needle Knife Fistulotomy Versus Partial Ampullary Endoscopic Mucosal Resection for Difficult Biliary Cannulation N/A
Recruiting NCT06053333 - Social Determinants of Health in Hepatobiliary Cancer Patients
Not yet recruiting NCT03195075 - Endoscopic Ultrasonography Guided Biliary Drainage N/A
Completed NCT03112668 - Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners N/A
Completed NCT02265341 - Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions Phase 2
Recruiting NCT04704661 - Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial Phase 1
Recruiting NCT05334069 - Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection